In this first instalment of the Open Pharma podcast, we look at the benefits of open access and how best to avoid predatory publishers. We speak with Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, about his passion for open access and his concerns about the potential impact of predatory publishing on the dissemination of medical research. Mary Yianni, Publisher at Taylor and Francis, then gives her insights into how to spot a predatory publisher.
No results yet.
Create your
podcast in
minutes
It is Free